MedPath

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Not Applicable
Completed
Conditions
Contact Lens Wearer
Interventions
Device: samfilcon A Lenses with EPG01 Packaging Solution
Device: B+L Ultra Lenses
Registration Number
NCT05126953
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
  2. Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
  3. Have no active ocular disease or allergic conjunctivitis.
  4. Not be using any topical ocular medications.
  5. Be willing and able to follow instructions.
  6. Have signed a statement of informed consent.
Exclusion Criteria
  1. Participating in a conflicting study in the opinion of the Investigator.
  2. Considered by the Investigator to not be a suitable candidate for participation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
samfilcon A Lenses with EPG01 Packaging Solutionsamfilcon A Lenses with EPG01 Packaging Solution-
B+L Ultra LensesB+L Ultra Lenses-
Primary Outcome Measures
NameTimeMethod
Normalized logMAR Visual Acuity2 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bausch and Lomb Site 01

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath